Bridgefront Capital, LLC Emergent Bio Solutions Inc. Transaction History

Bridgefront Capital, LLC

  • $249 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$7.79 - $16.29 $201,605 - $421,585
25,880 New
25,880 $268,000
Q2 2021

Aug 12, 2021
SELL
$56.61 - $80.46 $439,576 - $624,771
-7,765 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$86.23 - $125.19 $669,575 - $972,100
7,765 New
7,765 $721,000

Others Institutions Holding EBS

# of Institutions
159
Shares Held
33.7M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $463M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email